CAHD

RESULTS: Totally 67 CAHD patients and 20 healthy subjects entered the final analysis.

结果：冠心病患者67例和健康者20名均进入结果分析。

CONCLUSION: There is an important correlation between the substitution of PPAR γ C161 → T and CAHD, and "T" allele carriers demonstrate a lower risk of CAHD.

结论：过氧化物酶体增殖物激活受体γC161→T的置换与冠状动脉粥样硬化性心脏病之间有重要的相关性，T等位基因携带者发生冠状动脉粥样硬化性心脏病的危险性较少。

Objective: To investigate the therapeutic efficacy of Yiqi Huoxue Recipe on left ventricular insufficiency with coronary atherosclerotic heart disease ( CAHD).

目的：探讨益气活血方对冠状动脉粥样硬化性心脏病（冠心病）患者左心室功能不全的治疗效果。

OBJECTIVE: At present, coronary atherosclerotic heart disease ( CAHD) has become the first cause of female death in developed country.

目的：目前在发达国家冠状动脉粥样硬化性心脏病（冠心病）已成为妇女死亡的第一原因。

Results In order of significance the factors affecting hospitalization expenses of CAHD are hospitalization duration, character of medical fee, operation and age.

结果：影响冠心病患者住院费用的因素依贡献大小分别为住院天数、费别、有无手术、年龄。

Conclusions: The composite salvia miltiorrhiza dropping pill possesses better curative effects on angina of CAHD.

结论：复方丹参滴丸对冠心病心绞痛有较好疗效；

Objective To observe and evaluate the clinical effect of Huoxin capsule on angina pectoris of coronary atherosclerosis heart disease ( CAHD).

目的观察和探讨活心丸治疗冠心病心绞痛的临床疗效。